首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES OR IMMUNE DISEASES COMPRISING 4-HYDROXY-2,3-DIMETHYL-2-NONEN-4-OLIDE OR 3-HYDROXY-4,7-MEGASTIGMADIEN-9-ONE COMPOUND AS ACTIVE INGREDIENT

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES OR IMMUNE DISEASES COMPRISING 4-HYDROXY-2,3-DIMETHYL-2-NONEN-4-OLIDE OR 3-HYDROXY-4,7-MEGASTIGMADIEN-9-ONE COMPOUND AS ACTIVE INGREDIENT

机译:预防和治疗包含4-羟基-2,3-二甲基-2-壬烯-4-壬烯化物或3-羟基-4,7-MEGASTIGMADIEN-9-作为活性成分的发炎性疾病或免疫性疾病的药物组合物

摘要

The present invention relates to a compound capable of effectively preventing or treating inflammatory diseases or immune diseases. Specifically, 4-hydroxy-2,3-dimethyl-2-nonen-4-olide compound or 3-hydroxy-4,7-megastigmadien-9-one compound according to the present invention, suppresses the phosphorylation of IκBα as well as activates (phosphorylation) of MAPK family members, ERK, JNK, and p38, and ultimately through a mechanism of suppressing the activation of transcriptional factors, NF-κB and AP-1, can effectively suppress the production of inflammatory cytokines, IL-12, IL-6, or TNF-α. Thus, the present invention can be beneficially used in various industries such as drug, cosmetics, and food industries as a material capable of preventing, alleviating, or treating various inflammatory diseases and autoimmune diseases arising from abnormal regulation of immune responses.;COPYRIGHT KIPO 2017
机译:本发明涉及能够有效预防或治疗炎性疾病或免疫疾病的化合物。具体地,根据本发明的4-羟基-2,3-二甲基-2-壬烯-4-醇化物或3-羟基-4,7-巨stigmadien-9-化合物抑制IκB的磷酸化。以及激活(磷酸化)MAPK家族成员ERK,JNK和p38,并最终通过抑制转录因子激活的机制NF-κB和AP-1,可以有效抑制炎症性细胞因子的产生,IL-12,IL-6或TNF-α。因此,本发明可以作为能够预防,减轻或治疗由于免疫应答的异常调节而引起的各种炎性疾病和自身免疫性疾病的材料而在药物,化妆品和食品工业等各种工业中有用。COPYRIGHTKIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号